In this context, previous studies have indicated that MDS bone marrow cells harboring del(5q) are dependent on TRAF6-mediated NF-κB signaling, an essential regulator of innate immunity and inflammation [36,38]. The gene discussed is NFKB1; the disease is myelodysplastic syndrome.